Net Loss of Krebs Biochemicals & Industries reported to Rs 4.98 crore in the quarter ended December 2023 as against net loss of Rs 5.55 crore during the previous quarter ended December 2022. Sales rose 42.79% to Rs 12.98 crore in the quarter ended December 2023 as against Rs 9.09 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales12.989.09 43 OPM %-16.10-32.78 - PBDT-3.25-3.86 16 PBT-4.98-5.55 10 NP-4.98-5.55 10 Powered by Capital Market - Live News

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 12 February 2024.Powered by Capital Market - Live News

Net Loss of Krebs Biochemicals & Industries reported to Rs 3.57 crore in the quarter ended September 2023 as against net loss of Rs 4.06 crore during the previous quarter ended September 2022. Sales declined 28.89% to Rs 14.89 crore in the quarter ended September 2023 as against Rs 20.94 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales14.8920.94 -29 OPM %-6.04-9.07 - PBDT-1.86-2.37 22 PBT-3.57-4.06 12 NP-3.57-4.06 12 Powered by Capital Market - Live News

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Company on 8 November 2023.Powered by Capital Market - Live News

Krebs Biochemicals & Industries announced that the 31th Annual General Meeting (AGM) of the company will be held on 27 September 2023.Powered by Capital Market - Live News